000 01205 a2200349 4500
005 20250517195158.0
264 0 _c20190318
008 201903s 0 0 eng d
022 _a1750-1172
024 7 _a10.1186/s13023-018-0761-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStein, Susan
245 0 0 _aPrinciples for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases.
_h[electronic resource]
260 _bOrphanet journal of rare diseases
_c01 2018
300 _a18 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aDecision Making
650 0 4 _aHumans
650 0 4 _aPatient Advocacy
650 0 4 _aPublic Health
650 0 4 _aRare Diseases
700 1 _aBogard, Elizabeth
700 1 _aBoice, Nicole
700 1 _aFernandez, Vivian
700 1 _aField, Tessa
700 1 _aGilstrap, Alan
700 1 _aKahn, Susan R
700 1 _aLarkindale, Jane
700 1 _aMathieson, Toni
773 0 _tOrphanet journal of rare diseases
_gvol. 13
_gno. 1
_gp. 18
856 4 0 _uhttps://doi.org/10.1186/s13023-018-0761-2
_zAvailable from publisher's website
999 _c28003258
_d28003258